Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells

Journal of Clinical Investigation

Volumn 97, Issue 3, 1996, Pages 884-890

  Ehrenwald, Eduardo ^a   Fox, Paul L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ceruloplasmin; lipid peroxidation; low density lipoprotein; monocytic cells; zymosan

Indexed keywords

ACUTE PHASE PROTEIN; CERULOPLASMIN; COMPLEMENTARY DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN G; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; POLYCLONAL ANTIBODY; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ZYMOSAN;

ARTICLE; ATHEROGENESIS; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0030062182     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118491     Document Type: Article

References (58)

1. Nathan, C.F. 1987. Secretory products of macrophages. J. Clin. Invest. 79. 319-326.
2. Yla-Herttuala, S. 1991. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann. Med. 23:561-567.
3. Stampfer, M.J , C.H. Hennekens, J.E. Manson, G.A Colditz, B. Rosner, and W.C. Willett. 1993. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:1444-1449.
4. Babbs, C.F. 1992. Oxygen radicals in ulcerative colitis. Free Radical Biol. & Med. 13:169-181.
5. Koppenol, W.H., J. Butler, and J.W. van Leenwen. 1978 The Haber-Weiss cycle. Photochem. Photobiol. 28:655-678.
6. Cathcart, M.K., A.K. McNally, D.W. Morel, and G.M. Chisolm. 1989. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. J. Immunol. 142:1963-1969.
7. McNally, A.K., G.M. Chisolm, D W. Morel, and M.K. Cathcart. 1990. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway. J. Immunol 145:254-259.
8. Morel, D.W., P.E. DiCorleto, and G M. Chisolm. 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation Arteriosclerosis. 4:357-364.
9. Heinecke, J.W., H. Rosen, L.A. Suzuki, and A. Chait. 1987. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:10098-10103.
10. 2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytes. J Clin. Invest. 91:1499-1506.
11. Robinson, J.M., and J.A. Badwey. 1994. Production of active oxygen species by phagocytic leukocytes. In Macrophage-Pathogen Interactions. B.S. Zwilling and T.K. Eisenstein, editors. Marcel Dekker, New York 159-178.
12. Ehrenwald, E., G.M. Chisolm, and P.L. Fox 1994. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J. Clin. Invest. 93:1493-1501.
13. Rydén, L. 1984 Ceruloplasmin. In Copper proteins and copper enzymes, vol. III. R. Lontie, editor. CRC Press, Boca Raton, FL. 37-100
14. Fox, P L., C. Mukhopadhyay, and E. Ehrenwald 1995. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci. 56:1749-1758
15. Samokyszyn, V.M., D.M. Miller, D.W Reif, and S.D. Aust. 1989 Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. J. Biol. Chem. 264:21-26.
16. Al-Timimi, D J., and T.L. Dormandy. 1977. The inhibition of lipid autoxidation by human caeruloplasmin. Biochem J. 168:283-288
17. Lamb, D.J , and D.S. Leake. 1994. Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein FEBS Lett. 338:122-126.
18. Swain, J.A., V. Darley-Usmar, and J.M C Gutteridge. 1994. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis FEBS Lett. 342.49-52.
19. Cousins, R.J. 1985. Absorption, transport, and hepatic metabolism of copper and zinc, special reference to metallothionein and ceruloplasmin. Physiol. Rev 65:238-309.
20. Reunanen, A., P. Knekt, and R.-K. Aaran. 1992. Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am. J. Epidemiol. 136: 1082-1090.
21. Mänttäri, M , V. Manninen, J.K. Huttunen, T. Palosuo, C. Ehnholm, O.P. Heinonen, and M.H Frick. 1994. Serum ferritin and ceruloplasmin as coronary risk factors. Eur. Heart J 15:1599-1603.
22. Craig, W.Y., S E. Poulin, G.E Palomaki, L.M. Neveux, R F. Ritchie, and T.B. Ledue. 1995. Oxidation-related analytes and lipid and lipoprotein concentrations in healthy subjects. Arterioscler. Thromb. Vasc. Biol. 15:733-739.
23. 2-macroglobulin. Atherosclerosis. 34:391-405.
24. Swain, J , and J.M C. Gutteridge. 1995. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material FEBS Lett. 368:513-515
25. Gitlin, J D. 1988. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J. Biol. Chem. 263:6281-6287.
26. Milland, J., A. Tsykin, T. Thomas, A.R. Aldred, T. Cole, and G. Schreiber. 1990. Gene expression in regenerating and acute-phase rat liver. Am J Physiol 259:G340-G347
27. Fleming, R E., I.P. Whitman, and J.D. Gitlin. 1991. Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. Am. J. Physiol. 260:L68-L74.
28. Ehrenwald, E., and P.L. Fox. 1994. Isolation of nonlabile human ceruloplasmin by chromatographic removal of a plasma metalloproteinase. Arch. Biochem Biophys. 309:392-395.
29. Noyer, M., F.E Dwulet, Y L Hao, and F.W. Putnam. 1980. Purification and characterization of undegraded human ceruloplasmin Anal. Biochem 102: 450-458.
30. Sunderman, F.W., and S. Nomoto. 1970. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin. Chem. 16:903-910.
31. Rydén, L , and I. Björk. 1976. Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase). Biochemistry. 15:3411-3417.
32. r 200,000 form. J Biol. Chem. 265:2533-2537
33. Kosugi, K., D.W. Morel, P.E. DiCorleto, and G.M. Chisolm 1987. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle. J. Cell. Physiol 130:311-320.
34. Schuh, J., G.F. Fairclough, and R H. Haschemeyer. 1978. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl. Acad. Sci USA. 75:3173-3177.
35. Chirgwin, J.M., R.J. Przybyla, R J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease Biochemistry 18:5294-5299.
36. Cathcart, M.K., G.M. Chisolm, A.K. McNally, and D W. Morel. 1988. Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60. In Vitro Cell. & Dev Biol. 24 1001-1008.
37. Cathcart, M.K., D.W. Morel, and G.M. Chisolm. 1985. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J. Leukocyte Biol. 38.341-350.
38. Fleming, R.E., and J.D. Gitlin. 1990. Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J. Biol. Chem. 265:7701-7707
39. Lunec, J., D.R. Blake, S.J. McCleary, S. Brailsford, and P.A Bacon. 1985. Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J. Clin. Invest. 76:2084-2090.
40. Lindstedt, K.A. 1993 Inhibition of macrophage-mediated low density lipoprotein oxidation by stimulated rat serosal mast cells. J. Biol. Chem. 268: 7741-7746.
41. Katsura, M., L A. Forster, G.A.A. Ferns, and E.E. Anggård. 1994. Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway. Biochim Biophys Acta. 1213:231-237.
42. Jaeger, J.A., D H. Turner, and M. Zuker. 1989. Improved predictions of secondary structures for RNA. Proc Natl Acad Sci. USA. 86:7706-7710.
43. Li, Q , and M.K. Cathcart. 1994. Protein kinase C activity is required for lipid oxidation of low density lipoprotein by activated human monocytes. J. Biol. Chem. 269.17508-17515
44. Hiramatsu, K., H Rosen, J.W. Heinecke, G. Wolfbauer, and A. Chait 1987. Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis. 7:55-60.
45. Jessup, W., J.A. Simpson, and R.T. Dean. 1993. Does superoxide radical have a role in macrophage-mediated oxidative modification of LDL? Atherosclerosis. 99:107-120.
46. - Biochem. Int. 17:783-790.
47. Sparrow, C.P., and J. Olszewski. 1993. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res 34.1219-1228
48. Darley-Usmar, V M., N. Hogg, V J. O'Leary, M.T. Wilson, and S. Moncada. 1992. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radical Res. Commun. 17:9-20.
49. 2 mimics cell-mediated oxidative modification. J. Lipid Res 29:745-753.
50. Folcik, V.A., and M.K. Cathcart. 1993. Assessment of 5-lipoxygenase involvement in human monocyte-mediated LDL oxidation. J. Lipid Res. 34:69-79.
51. Sparrow, C P., and J. Olszewski. 1992. Cellular oxidative modification of low density lipoprotein does not require lipoxygenases. Proc. Natl. Acad. Sci. USA. 89 128-131.
52. Rankin, S.M., S. Parthasarathy, and D. Steinberg. 1991. Evidence of a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J. Lipid Res. 32:449-456.
53. Winyard, P.G., R.C. Hider, J. Lunec, A.F. Drake, and D.R. Blake. 1988. Role of oxidative modification in the lability of ceruloplasmin. Basic Life Sci. 49:341-345.
54. Kataoka, M , and M. Tavassoli. 1985. Identification of ceruloplasmin receptors on the surface of human blood monocytes, granulocytes, and lymphocytes Exp. Hematol. 13:806-810.
55. Aviram, M., and M. Rosenblat. 1994 Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J. Lipid Res. 35:385-398.
56. Cathcart, M K , Q Li, and G.M. Chisolm. 1995 Lipoprotein receptor interactions are not required for monocyte oxidation of LDL. J. Lipid Res. 36: 1857-1865.
57. Yang, F., S.L Naylor, J.B. Lum, S. Cutshaw, J.L. McCombs, K.H. Naberhaus, J R. McGill, G.S Adrian, C.M. Moore, D R. Barnett, and B.H. Bowman 1986. Characterization, mapping, and expression of the human ceruloplasmin gene Proc. Natl. Acad. Sci. USA. 83:3257-3261.
58. Lynch, S.M., and B. Frei. 1993. Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein. J. Lipid Res. 34: 1745-1753.